68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

Clinical trial NCT05847348 · UNKNOWN

Trial details

NCT number: NCT05847348
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Biochemical Recurrence of Malignant Neoplasm of Prostate Prostate Cancer BCR Prostate Carcinoma

Start date: 2023-07-19
Primary completion: 2025-12-30
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.